Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Neoplasms of the CNS

Free Subscription 19.11.2018 1 Cancer Res 2 Childs Nerv Syst 3 Int J Cancer 1 Int J Radiat Oncol Biol Phys 2 J Neurooncol 3 Neuro Oncol 1 Neurosurgery

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Cancer Res

1. MA L, Lin K, Chang G, Chen Y, et al
   Aberrant activation of beta-catenin signaling drives glioma tumorigenesis via USP1-mediated stabilization of EZH2.
   Cancer Res. 2018 Nov 13. pii: 0008-5472.CAN-18-1304.
   PubMed     Text format     Abstract available
   
   

   
   Childs Nerv Syst

2. ABU ARJA MH, Stanek JR, Morales La Madrid AE, Lassaletta A, et al
   The Latin American Brain Tumor Board teleconference: results of a web-based survey to evaluate participant experience utilizing this resource.
   Childs Nerv Syst. 2018 Nov 14. pii: 10.1007/s00381-018-4000.
   PubMed     Text format     Abstract available
   
   
3. KEBUDI R, Cakir FB, Bay SB, Gorgun O, et al
   Nimotuzumab-containing regimen for pediatric diffuse intrinsic pontine gliomas: a retrospective multicenter study and review of the literature.
   Childs Nerv Syst. 2018 Nov 11. pii: 10.1007/s00381-018-4001.
   PubMed     Text format     Abstract available
   
   

   
   Int J Cancer

4. SELIGER C, Gerken M, Leitzmann MF, Hau P, et al
   Reply to Lu: Connecting the dots between metformin and high-grade glioma.
   Int J Cancer. 2018 Nov 13. doi: 10.1002/ijc.31990.
   PubMed     Text format    
   
   
5. LU VM
   Connecting the dots between metformin and high-grade glioma.
   Int J Cancer. 2018 Nov 13. doi: 10.1002/ijc.31987.
   PubMed     Text format    
   
   
6. CORBETTA C, Di Ianni N, Bruzzone MG, Patane M, et al
   Altered function of the glutamate-aspartate transporter GLAST, a potential therapeutic target in glioblastoma.
   Int J Cancer. 2018 Nov 12. doi: 10.1002/ijc.31985.
   PubMed     Text format     Abstract available
   
   

   
   Int J Radiat Oncol Biol Phys

7. CHERLOW JM, Shaw DW, Margraf LR, Bowers DC, et al
   Conformal Radiation Therapy for Pediatric Patients with Low-Grade Glioma: Results from the Children's Oncology Group Phase II Study XXXX.
   Int J Radiat Oncol Biol Phys. 2018 Nov 9. pii: S0360-3016(18)33951.
   PubMed     Text format     Abstract available
   
   

   
   J Neurooncol

8. OLSSON A, Bouaoun L, Auvinen A, Feychting M, et al
   Survival of glioma patients in relation to mobile phone use in Denmark, Finland and Sweden.
   J Neurooncol. 2018 Nov 12. pii: 10.1007/s11060-018-03019.
   PubMed     Text format     Abstract available
   
   
9. OUADAH NS, Lecomte A, Robidel F, Olsson A, et al
   Possible effects of radiofrequency electromagnetic fields on in vivo C6 brain tumors in Wistar rats.
   J Neurooncol. 2018 Nov 12. pii: 10.1007/s11060-018-03012.
   PubMed     Text format     Abstract available
   
   

   
   Neuro Oncol

10. SCHIFF D, de Groot JF
    Lower-grade gliomas: the wrong target for bevacizumab.
    Neuro Oncol. 2018;20:1559-1560.
    PubMed     Text format    
    
    
11. SPERDUTO PW, Deegan BJ, Li J, Jethwa KR, et al
    Estimating survival for renal cell carcinoma patients with brain metastases: an update of the Renal Graded Prognostic Assessment tool.
    Neuro Oncol. 2018;20:1652-1660.
    PubMed     Text format     Abstract available
    
    
12. EISEMANN T, Costa B, Harter PN, Wick W, et al
    Podoplanin expression is a prognostic biomarker but may be dispensable for the malignancy of glioblastoma.
    Neuro Oncol. 2018 Nov 10. pii: 5168873. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    

    
    Neurosurgery

13. HENDRIKS EJ, Idema S, Hervey-Jumper SL, Bernat AL, et al
    Preoperative Resectability Estimates of Nonenhancing Glioma by Neurosurgeons and a Resection Probability Map.
    Neurosurgery. 2018 Nov 10. pii: 5178544. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Neoplasms of the CNS is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: